Literature DB >> 21376831

[Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: results from the FUNGEMYCA study].

Javier Pemán1, Emilia Cantón, Juan José Camarena Miñana, Julia Alcoba Florez, Julia Echeverria, David Navarro Ortega, José Martínez Alarcón, Dionisia Fontanals, Bárbara Gomila Sard, Buenaventura Buendía Moreno, Luis Torroba, Josefina Ayats, Miguel Ángel Bratos Pérez, María Alvarez Fernández, Ferrán Sánchez Reus, Isabel Fernández Natal, Gloria Royo García, Guillermo Ezpeleta, Estrella Martín-Mazuelos, Isabel Iglesias, Antonio Rezusta, Inmaculada Ramírez de Ocariz, Amelia Gómez Nieto.   

Abstract

BACKGROUND: Recent epidemiological surveillance studies have reported an increase in fungaemia caused by non-Candida albicans species, as well as a decrease in fluconazole susceptibility.
OBJECTIVES: To evaluate changes in the epidemiology of fungaemia in Spain comparing data from a new surveillance epidemiological study conducted in 2009 with a previous study carried out from 1997 to 1999 (Pemán J, et al. Eur J Clin Microbiol Infect Dis. 2005).
METHODS: From January 2009 to February 2010, 44 Spanish hospitals participated in a prospective multicentre fungaemia surveillance study to ascertain whether there have been changes in the epidemiology and fluconazole susceptibility. Susceptibility was determined by the colorimetric method Sensititre Yeast One. Demographic and clinical data and the first isolate of each episode were gathered.
RESULTS: A total of 1,377 isolates from 1,357 fungaemia episodes were collected, 46.7% from patients older than 64years and 8.6% from children less than 1 year old. C. albicans (44.7%), Candida parapsilosis (29.1%), Candida glabrata (11.5%), Candida tropicalis (8.2%), and Candida krusei (1.9%) were the most frequent species isolated. Distribution varied with the geographical area. C. albicans incidence has increased significantly in the last 10years in Cataluña (39.1 vs. 54.7%, P=0.03) and decreased in the Valencian Community (49.1 vs. 34.6%, P=0.002) and Extremadura (58.3 vs. 20%, P=0.01). Susceptibility to fluconazole was similar for all geographical areas, although resistance in C. albicans was ten times greater for patients aged more than 64years. The overall rate of fluconazole resistance (MIC > 32 mg/L) has decreased with respect to that obtained 10years ago (3.7 vs. 2.5%) mainly in C. albicans (3 vs. 1.6%).
CONCLUSIONS: In the last ten years, species distribution and fluconazole susceptibility have not significantly changed, although a lower rate of fluconazole resistance has been observed. Species distribution varies with hospital, hospitalization Unit and geographical area.
Copyright © 2010 Revista Iberoamericana de Micología. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21376831     DOI: 10.1016/j.riam.2011.02.005

Source DB:  PubMed          Journal:  Rev Iberoam Micol        ISSN: 1130-1406            Impact factor:   1.044


  7 in total

1.  Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.

Authors:  Emilia Cantón; Javier Pemán; Guillermo Quindós; Elena Eraso; Ilargi Miranda-Zapico; María Álvarez; Paloma Merino; Isolina Campos-Herrero; Francesc Marco; Elia Gomez G de la Pedrosa; Genoveva Yagüe; Remedios Guna; Carmen Rubio; Consuelo Miranda; Carmen Pazos; David Velasco
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey.

Authors:  Javier Pemán; Emilia Cantón; María José Linares-Sicilia; Eva María Roselló; Nuria Borrell; María Teresa Ruiz-Pérez-de-Pipaon; Jesús Guinea; Julio García; Aurelio Porras; Ana María García-Tapia; Luisa Pérez-Del-Molino; Anabel Suárez; Julia Alcoba; Inmaculada García-García
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

3.  Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center.

Authors:  Laura Judith Marcos-Zambrano; Pilar Escribano; Carlos Sánchez; Patricia Muñoz; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

4.  The Etest Performed Directly on Blood Culture Bottles Is a Reliable Tool for Detection of Fluconazole-Resistant Candida albicans Isolates.

Authors:  Pilar Escribano; Laura Judith Marcos-Zambrano; Ana Gómez; Carlos Sánchez; M Carmen Martínez-Jiménez; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

5.  Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years.

Authors:  M A De Francesco; G Piccinelli; M Gelmi; F Gargiulo; G Ravizzola; G Pinsi; L Peroni; C Bonfanti; A Caruso
Journal:  Mycopathologia       Date:  2017-06-08       Impact factor: 2.574

6.  Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis virulence in the non-conventional host Galleria mellonella.

Authors:  Sara Gago; Rocío García-Rodas; Isabel Cuesta; Emilia Mellado; Ana Alastruey-Izquierdo
Journal:  Virulence       Date:  2013-11-05       Impact factor: 5.882

Review 7.  Revisiting Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates from Latin American Medical Centers.

Authors:  Daniel Archimedes da Matta; Ana Carolina Remondi Souza; Arnaldo Lopes Colombo
Journal:  J Fungi (Basel)       Date:  2017-05-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.